IOF vs. TET, SYNT, HAYD, WCH, ITX, DCTA, HDD, BIOM, VRS, and ZED
Should you be buying Iofina stock or one of its competitors? The main competitors of Iofina include Treatt (TET), Synthomer (SYNT), Haydale Graphene Industries (HAYD), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), Hardide (HDD), Biome Technologies (BIOM), Versarien (VRS), and Zenova Group (ZED). These companies are all part of the "specialty chemicals" industry.
Iofina vs. Its Competitors
Treatt (LON:TET) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk, analyst recommendations and media sentiment.
42.1% of Treatt shares are held by institutional investors. Comparatively, 0.5% of Iofina shares are held by institutional investors. 4.1% of Treatt shares are held by insiders. Comparatively, 13.4% of Iofina shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, Iofina had 2 more articles in the media than Treatt. MarketBeat recorded 2 mentions for Iofina and 0 mentions for Treatt. Treatt's average media sentiment score of 0.00 equaled Iofina'saverage media sentiment score.
Treatt has higher revenue and earnings than Iofina. Iofina is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.
Treatt currently has a consensus price target of GBX 266.67, suggesting a potential upside of 4.58%. Iofina has a consensus price target of GBX 40, suggesting a potential upside of 61.13%. Given Iofina's stronger consensus rating and higher possible upside, analysts clearly believe Iofina is more favorable than Treatt.
Treatt has a net margin of 7.88% compared to Iofina's net margin of 6.98%. Treatt's return on equity of 8.09% beat Iofina's return on equity.
Treatt has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Comparatively, Iofina has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500.
Summary
Treatt beats Iofina on 10 of the 14 factors compared between the two stocks.
Get Iofina News Delivered to You Automatically
Sign up to receive the latest news and ratings for IOF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding IOF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:IOF) was last updated on 10/16/2025 by MarketBeat.com Staff
